Home » Topics » Conferences

Conferences
RSS

New 5-HT1A receptor antagonist from Astra Arcus undergoes extensive preclinical testing

Nov. 9, 1998

Neuroprotective agents with dual NOS-inhibitory and antioxidant effects synthesized at French lab

Nov. 9, 1998

NPS-2390: representative of a novel class of potent and selective group I mGluR antagonists

Nov. 9, 1998

Droloxifene effects on lipid parameters evaluated in healthy postmenopausal women

Nov. 9, 1998

In vitro and in vivo pharmacology of CP-465022 presented at neuroscience meeting

Nov. 9, 1998

Novel proteasome inhibitor effective in animal model of stroke

Nov. 9, 1998

APLAUD study evaluates SB-214857 in patients with coronary artery and cerebrovascular disease

Nov. 9, 1998

Effects of new free radical scavenger MDL-100002 in embolic stroke

Nov. 9, 1998

Centrally selective nAChR ligand from R.J. Reynolds considered Alzheimer's disease candidate

Nov. 9, 1998

Selective M2 receptor antagonist from Schering-Plough with potential in AD

Nov. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...